5 Stocks to Watch: Week of 10/13/2025

By Jessie Moore, Stock Researcher and Writer

October 10, 2025 6:41 PM UTC

APH

President Trump may have dropped a bombshell on the market last Friday, but there are still plenty of high-quality stocks to watch in the coming week:

Amphenol (APH) just got a Strong Buy upgrade from a top 1% analyst
Teva Pharmaceutical Industries (TEVA) ONLY has Strong Buy ratings among the experts we track
Borgwarner (BWA) is a top-rated stock in a top-rated industry
Primoris Services (PRIM) is a top-rated stock in a top-rated industry
Hubbell (HUBB) earns top grades for Safety and Financials

Let's get to it. (P.S. Missed last week's picks? Get them here.)

A note from our sponsors...

Here's the Best Day to Buy Stocks Did you know the S&P 500 has a 100% history of soaring, beginning on one particular day every fall? We call this the "Green Day phenomenon." It works on 5,000 stocks. For example, Nvidia has a 100% history of soaring beginning on one particular day every single year. Click here to see the green days for 7 major stocks today.

1- Amphenol (NYSE: APH)

Amphenol supplies connectors, cables, and sensors to industries ranging from automotive and aerospace to IT, mobile devices, and industrial equipment. A behind-the-scenes play with exposure to a variety of high-growth sectors, APH is set to benefit from strong auto demand. In addition, management and key company personnel seem quite bullish, as they’ve been scooping up shares lately.

Zen Rating: B (Buy) — see full analysis >

Recent Price: $122.60 — get current quote >

Max 1-year forecast: $145.00

Why we’re watching:

Analyst coverage of Amphenol is overwhelmingly positive — the stock has 5 Strong Buy ratings, 2 Buy ratings, and 2 Hold ratings. See the ratings
Mark Delaney of Goldman Sachs (a top 2% rated analyst) recently reiterated a Strong Buy rating on APH shares, and upped his price forecast from $124 to $139.
Delaney contextualized their price target hike on Amphenol by telling readers that Goldman Sachs raised its FY 2025 U.S. auto forecast from 15.75M to 16.2M and its FY 2026 forecast from 15.5M to 16M vehicles delivered based on "solid YTD sales.
The analyst explained that their firm's leading indicators analysis implies stronger demand for vehicles, and "relatively benign" pricing actions from the industry in response to tariffs.
Goldman Sachs reduced its U.S. BEV mix assumptions for FY 2026 and beyond, Delaney added.
A couple of days before Delaney’s revised coverage, Citigroup’s Asiya Merchant (a top 1% rated analyst) also doubled down on a Strong Buy rating, and hiked her price target from $125 to a Street-high $145.
In a Connector sector overview note, Merchant said they hiked estimates for the group to account for rising hyperscaler spending and improving margin commentary.
Connector names should continue to see margin expansion from strong demand for connectivity solutions in AI applications, the analyst detailed.
APH is currently the 11th highest-rated stock in the Electronic Component industry, which has an Industry Rating of A.
Amphenol currently ranks in the top 7% of the equities that we track, giving it a Zen Rating of B, which has historically corresponded to an average annual return of 19.88%.
Our Sentiment Component Grade rating takes into account factors such as earnings surprises, analyst coverage, short interest, and insider action. The last factor is crucial in APH’s case — 50.73% of the insider transactions tied to the stock in the past 12 months have been purchases. In this category, Amphenol ranks in the 96th percentile of stocks.
However, Momentum, where APH ranks in the top 3%, is the stock’s strongest suit — owing to an 81.32% year-to-date (YTD) gain. (See all 7 Zen Component Grades here >)

2- Primoris Services (NYSE: PRIM)

Primoris is a specialty contractor that covers everything from construction and fabrication to maintenance and replacement in the high-growth area of renewable, industrial-scale energy. With infrastructure spending set to increase substantially, and a record $11.4 billion backlog already on the books, PRIM currently looks like one of the businesses that is best-positioned to take advantage of the clean energy revolution.

Zen Rating: A (Strong Buy) — see full analysis >

Recent Price: $134.79 — get current quote >

Max 1-year forecast: $160.00

Why we’re watching:

Primoris Services enjoys broad, overwhelmingly positive coverage from Wall Street analysts — the stock currently has 8 Strong Buy ratings and 1 Hold rating. See the ratings
Steven Fisher of UBS (a top 7% rated analyst) recently maintained a Strong Buy rating on the stock and increased his price target from $135 to $158.
PRIM is the 5th highest-rated stock in the Engineering & Construction industry, which has an Industry Rating of A.
Primoris Services currently ranks in the top 2% of the stocks that we track, giving it a Zen Rating of A.
PRIM is a rare sight in terms of how well-balanced it is. The stock ranks in the 80th percentile in terms of Safety and the 83rd percentile with regard to Financials.
On top of that, Primoris Services ranks in the top 7% when it comes to Momentum, as the stock has rallied by 78.86% since the start of the year.
Last but not least, we have Growth and Sentiment — both categories in which PRIM ranks in the top 6%. (See all 7 Zen Component Grades here >)

A note from our sponsors...

Apple's Starlink Update Sparks Huge Earning Opportunity Apple just secretly added Starlink satellite support to iPhones through iOS 18.3. One of the biggest potential winners? Mode Mobile. Mode's EarnPhone already reaches 50M+ users that have earned over $325M, and that's before global satellite coverage. With SpaceX eliminating "dead zones," Mode's earning technology can now reach billions more in unbanked and rural populations worldwide. Their global expansion is perfectly timed, and accredited investors still have a chance to invest in their pre-IPO offering at $0.50/share. With their recent 32,481% revenue growth and newly reserved Nasdaq ticker, Mode is one step closer to a potential IPO. Tap into a $1T opportunity - invest now at just $0.50/share and get up to 120% bonus. Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite

3- Qorvo (NASDAQ: QRVO)

Qorvo is a US-based semiconductor business that is in the middle of a turnaround. After a three-year period of declining estimates, a strong earnings beat has placed the company back in the limelight — but QRVO is still trading at a bargain price.

Zen Rating: A (Strong Buy) — see full analysis >

Recent Price: $85.04 — get current quote >

Max 1-year forecast: $125.00

Why we’re watching:

QRVO is our Stock of the Week. Our Editor-in-Chief, Steve Reitmeister, explained why the stock found a place in his exclusive, 20-stock strong Zen Investor portfolio in a Monday article. We’ll summarize some of the key points below.
As the company is based in the US and deals in semiconductors, which are increasingly seen as a national defense issue, Qorvo enjoys a unique advantage on the tariff front.
Estimates for the stock have been slipping for the better part of the last 3 years — but last quarter, QRVO provided a decisive 46% earnings beat, which has in turn inspired a slew of increased earnings estimates and fair value targets
At present, Qorvo is trading at roughly $91 — and if the ongoing turnaround ends up having traction, Steve believes that QRVO shares could push north of $150 in the coming year.
QRVO ranks in the top 3% of the stocks tracked by our system, giving it a Zen Rating of A
The stock offers a very compelling mix of Growth and Value — in the former category, it ranks in the top 19%, while also ranking in the top 8% when it comes to the latter.
On top of that, the company’s balance sheet is quite formidable — QRVO ranks in the 96th percentile of equities in terms of Financials. (See all 7 Zen Component Grades here >)

4- Teva Pharmaceutical Industries (NYSE: TEVA)

One of the world’s largest generic drug manufacturers, Teva Pharmaceutical Industries maintains a vast portfolio spanning hundreds of treatments. The company enjoys a dominant position in generics, and currently offers very compelling growth prospects at a very modest valuation.

Zen Rating: A (Strong Buy) — see full analysis >

Recent Price: $20.05 — get current quote >

Max 1-year forecast: $26.00

Why we’re watching:

Analyst coverage of TEVA is unanimously bullish — the stock currently has 5 Strong Buy ratings: See the ratings
The average 12-month price forecast for Teva Pharmaceutical Industries shares is currently pegged at $24, andi implies a hefty 19.64% upside.
Ashwani Verma of UBS (a top 26% rated analyst) recently maintained a Strong Buy rating on the stock, and increased his price target from $23 to a Street-high $26.
Verma contextualized their price target on Teva Pharmaceutical Industries by saying that "the stock can continue to see a relief rally until the Austedo IRA price is revealed on or before 2025/011/30.
Checks with payors imply that the potential IRA discount against list price on Austedo could be 40%, the analyst said.
TEVA is the 13th highest-rated stock in the Pharmaceutical industry, which has an Industry Rating of B.
Teva Pharmaceutical Industries ranks in the 95th percentile of the stocks that we track, giving the stock a Zen Rating of A.
TEVA offers a rare blend of Value and Growth — in both categories, the stock ranks in the top 10% of equities.
However, Teva Pharmaceutical Industries ranks even higher in terms of Safety — in the top 7% of stocks, to be precise (See all 7 Zen Component Grades here >)

5- Borgwarner (NYSE: BWA)

This past Stock of the Week selection is a global auto parts supplier best known for its powertrain and drivetrain technologies. The company services virtually every major automaker and has been engaged in a strong pivot toward electrification. Major Wall Street firms are expecting favorable conditions for the industry, and BWA, currently trading at a discount, is poised to benefit.

Zen Rating: A (Strong Buy) — see full analysis >

Recent Price: $44.11 — get current quote >

Max 1-year forecast: $54.00

Why we’re watching:

Borgwarner enjoys broad, bullish support from Wall Street analysts. The stock currently has 8 Strong Buy ratings, 2 Buy ratings, and 3 Hold ratings. See the ratings
Goldman Sachs equity researcher Kash Rangan (a top 12% rated analyst) recently maintained a Strong Buy rating on BWA, and increased his price target from $45 to $52.
Rangan contextualized their price target hike on BorgWarner by telling readers that Goldman Sachs raised its FY 2025 U.S. auto forecast from 15.75M to 16.2M and its FY 2026 forecast from 15.5M to 16M vehicles delivered based on "solid YTD sales.
The analyst explained that their firm's leading indicators analysis implies stronger demand for vehicles, and "relatively benign" pricing actions from the industry in response to tariffs.
Goldman Sachs reduced its U.S. BEV mix assumptions for FY 2026 and beyond, Rangan added.
BWA is the 6th highest-rated stock in the Auto Part industry, which has an Industry Rating of A.
Our quant rating system, Zen Ratings, uses 115 proprietary factors to evaluate roughly 4,600 stocks each day. Stocks that rank in the top 5% are given a Zen Rating of A, and have provided an average annual return of 32.52% since the early 2000s. At present, Borgwarner ranks in the top 2% of stocks.
Each Zen Rating is a composite of 7 Component Grade ratings, all of which focus on specific areas. For example, BWA is currently trading at an attractive price to earnings growth (PEG) ratio of 0.4x, and ranks in the top 16% of equities in terms of Value.
BWA also ranks in the 87th and 89th percentile when it comes to Safety and Financials, respectively
However, Borgwarner’s strongest suit is its Artificial Intelligence Component Grade rating. It is derived from the findings of a neural network trained on more than two decades of market data, which is used to identify likely outperformers. In this category, BWA ranks in the top 3% of stocks. (See all 7 Zen Component Grades here >)